Nitric oxide synthase gene therapy (Cardion/Valentis)

N/A

Report date: 2022/01/22 15:45:33

Base Information

Drug NameNitric oxide synthase gene therapy (Cardion/Valentis)

Drug Alias NameNOStentiniNOS gene therapy - Cardion/Valentis

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionNitric oxide synthase, inducible modulators

TargetsNitric oxide synthase, inducible

Therapy Area/IndicationsVascular restenosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesValentis Cardion

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCardion Valentis

Active IndicationsN/A

Inactive IndicationsVascular restenosis

ATC CodeN/A